Masimo (MASI) Share-based Compensation (2009 - 2026)
Masimo's (MASI) quarterly Share-based Compensation came in at $7.6 million in Q2 2026, down 32.74% year-on-year from $11.3 million in Q2 2025, and up 185.39% quarter-over-quarter from -$8.9 million in Q1 2026.
Masimo (MASI) Share-based Compensation (2009 - 2026) Analysis & Trends
Masimo's Share-based Compensation history runs 18 years deep, the most recent figure standing at $7.6 million for Q2 2026.
- On a quarterly basis, Share-based Compensation fell 32.74% year-over-year to $7.6 million in Q2 2026; TTM through Apr 2026 was $14.3 million, a 19.66% decrease from a year earlier, with the FY2026 full-year figure at $18.0 million, up 52.54% from the prior year.
- Share-based Compensation advanced to $7.6 million in Q2 2026 per MASI's latest filing, from -$8.9 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $17.3 million in Q3 2022 and bottomed at -$14.6 million in Q3 2024.
- The 5-year median for Share-based Compensation is $7.6 million (2026), against an average of $4.5 million.
- Biggest YoY gain for Share-based Compensation was 214.18% in 2024; the steepest drop was 1227.27% in 2024.
- Year by year, Share-based Compensation stood at -$2.8 million in 2022, then soared by 403.57% to $8.5 million in 2023, then sank by 31.76% to $5.8 million in 2024, then jumped by 156.9% to $14.9 million in 2025, then slumped by 48.99% to $7.6 million in 2026.
- Per Business Quant, the three latest MASI Share-based Compensation figures stand at $7.6 million (Q2 2026), -$8.9 million (Q1 2026), and $14.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 7.60 Mn |
| Apr 4, 2026 | 7.60 Mn |
| Jan 3, 2026 | -8.90 Mn |
| Jan 3, 2026 | -8.90 Mn |
| Sep 27, 2025 | 14.90 Mn |
| Sep 27, 2025 | 14.90 Mn |
| Jun 28, 2025 | 700,000.00 |
| Jun 28, 2025 | 700,000.00 |
| Mar 29, 2025 | 11.30 Mn |
| Mar 29, 2025 | 11.30 Mn |
| Dec 28, 2024 | 5.80 Mn |
| Dec 28, 2024 | 5.80 Mn |
| Sep 28, 2024 | -14.60 Mn |
| Sep 28, 2024 | -14.60 Mn |
| Jun 29, 2024 | 15.30 Mn |
| Jun 29, 2024 | 15.30 Mn |
| Mar 30, 2024 | 5.30 Mn |
| Mar 30, 2024 | 5.30 Mn |
| Dec 30, 2023 | 8.50 Mn |
| Dec 30, 2023 | 8.50 Mn |